Microvascular Eye Disease May Help Lung Doctors See Vascular Damage in PAH

Embargoed Until May 21, 4 p.m. CT

FOR MORE INFORMATION, CONTACT:

Dacia Morris
[email protected]
ATS Office 212-315-8620 (until May 16)

Session: C97 Don't Stop Believing: Clinical Trials in Pulmonary Vascular Medicine
Abstract Presentation Time:  Tuesday, May 21, 4 p.m. CT
Location: Room D162/D164 (Level 1), Kay Bailey Hutchison Convention Center Dallas

Microvascular Eye Disease May Help Lung Doctors See Vascular Damage in PAH

Newswise — ATS 2019, Dallas, TX─ Retinal vascular tortuosity, a microvascular abnormality of the eye, may provide doctors with a noninvasive way of determining the extent of vascular remodeling in patients with pulmonary arterial hypertension, according to research presented at ATS 2019. In this study involving humans and mice, retinal vascular tortuosity was linked to pulmonary vascular remodeling, a hallmark of PAH, suggesting that the eye may provide important information about the health of the pulmonary circulation.

VIEW ABSTRACT

CONTACT FOR MEDIA
Nils Nickel, MD
[email protected]